# DG Capital Management, LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1512716. Source: https://holderbook.com/funds/1512716-dg-capital-management-llc/

- Reported value: $474.9M
- Positions: 22
- Weight of the ten largest: 83.7%
- Filed: 2026-08-12

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| TALEN ENERGY CORP | [TLN](https://holderbook.com/stocks/TLN/) | $148.2M | 102,507 | 31.2% | 3 |
| MERCURY GENL CORP NEW | [MCY](https://holderbook.com/stocks/MCY/) | $87.1M | 482,663 | 18.3% | 6 |
| X-ENERGY INC | [XE](https://holderbook.com/stocks/XE/) | $27.8M | 1,512,339 | 5.8% | 1 |
| GODADDY INC | [GDDY](https://holderbook.com/stocks/GDDY/) | $26.5M | 211,720 | 5.6% | 2 |
| ABIVAX SA | [ABVX](https://holderbook.com/stocks/ABVX/) | $25.2M | 122,267 | 5.3% | 1 |
| CBIZ INC | [CBZ](https://holderbook.com/stocks/CBZ/) | $21.2M | 660,000 | 4.5% | 1 |
| RIOT PLATFORMS INC | - | $19.1M | 9,500,000 | 4.0% | 3 |
| ISHARES TR | [IWM](https://holderbook.com/stocks/IWM/) | $15.0M | 0 | 3.2% | 1 |
| CAPRICOR THERAPEUTICS INC | [CAPR](https://holderbook.com/stocks/CAPR/) | $14.7M | 611,595 | 3.1% | 4 |
| MAGNERA CORP | [MAGN](https://holderbook.com/stocks/MAGN/) | $12.9M | 1,101,476 | 2.7% | 7 |
| BOSTON SCIENTIFIC CORP | [BSX](https://holderbook.com/stocks/BSX/) | $12.8M | 300,000 | 2.7% | 1 |
| GOLAR LNG LTD | [GLNG](https://holderbook.com/stocks/GLNG/) | $12.4M | 248,100 | 2.6% | 4 |
| BURFORD CAPITAL LIMITED | [BUR](https://holderbook.com/stocks/BUR/) | $9.2M | 2,244,180 | 1.9% | 15 |
| GOLAR LNG LTD | - | $8.5M | 7,500,000 | 1.8% | 1 |
| BLUE OWL CAPITAL INC | [OWL](https://holderbook.com/stocks/OWL/) | $8.4M | 962,954 | 1.8% | 2 |
| OKLO INC | [OKLO](https://holderbook.com/stocks/OKLO/) | $7.3M | 0 | 1.5% | 3 |
| MORGAN STANLEY DIRECT LENDIN | [MSDL](https://holderbook.com/stocks/MSDL/) | $7.2M | 475,537 | 1.5% | 2 |
| AZUL S A | - | $5.5M | 616,433 | 1.2% | 1 |
| GENESIS ENERGY L P | [GEL](https://holderbook.com/stocks/GEL/) | $4.0M | 135,140 | 0.8% | 9 |
| EQUILLIUM INC | [EQ](https://holderbook.com/stocks/EQ/) | $1.5M | 463,396 | 0.3% | 1 |
| UNITED THERAPEUTICS CORP DEL | [UTHR](https://holderbook.com/stocks/UTHR/) | $302.3K | 558 | 0.1% | 4 |
| ZOOZ STRATEGY LTD | - | $103.4K | 18,666 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +16.1% | +14.8% | +1.3% | 63% |
| Q4 2025 | +7.9% | +2.4% | +5.5% | 74% |
| Q3 2025 | +5.3% | +7.8% | -2.5% | 82% |
| Q2 2025 | +11.5% | +10.5% | +1.1% | 70% |
| Q1 2025 | +2.4% | -4.6% | +6.9% | 68% |
| Q4 2024 | -7.1% | +2.1% | -9.3% | 100% |
| Q3 2024 | +18.4% | +5.4% | +13.0% | 95% |
| Q2 2024 | -9.2% | +4.0% | -13.2% | 95% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $474.9M | 22 |
| Q1 2026 | $326.2M | 22 |
| Q4 2025 | $227.9M | 18 |
| Q3 2025 | $288.0M | 18 |
| Q2 2025 | $329.2M | 18 |
| Q1 2025 | $283.2M | 15 |
| Q4 2024 | $297.8M | 16 |
| Q3 2024 | $220.4M | 15 |
| Q2 2024 | $259.5M | 18 |
| Q1 2024 | $163.3M | 19 |
| Q4 2023 | $161.8M | 22 |
| Q3 2023 | $182.8M | 22 |